The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature, and other conventional methods are ineffective. GlobalData uses proprietary data and analytics to provide a comprehensive report on the topical absorbable hemostats devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the topical absorbable hemostats market in the US was Ethicon followed by Teleflex, Z-Medica, B. Braun Melsungen, Gelita Medical, CR Bard, Pfizer, Medtronic and Meril Life Sciences.
Topical absorbable hemostats are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. TAH products are often plant or gelatin based and act as mechanical barriers and/or help with vasoconstriction and a platform for platelet aggregation to slow the flow of blood and give the patient’s body time to form a clot. Flowable hemostats or fibrin sealants are tracked under the tissue sealants and adhesives market. Hemostats include active hemostats (thrombin-based hemostats), and combination and passive hemostats (oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, polysaccharide-based hemostats, collagen-based hemostats). Oxidized regenerated cellulose-based hemostats are poly anions that contain polyanhydroglucuronic acid as a functional unit to aid in the platelet adhesion and aggregation process resulting in coagulation. Gelatin is a protein developed by denaturing the collagen and polymerizing with nitrogen to produce a porous scaffold. Polysaccharide based hemostats are purified plant derived starch. Collagen is a protein derived from animal source.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the topical absorbable hemostats devices market within the US was expected to be over $100m in 2022.
For the latest complete market share analysis of topical absorbable hemostats device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
